Citations

Mayo Clinic

Showing 10 of 108522 citations.

Navigating Complications in Cardiac Pacemakers: A Comprehensive Review and Management Strategies
Sriramoju, Anil , Iyengar, Shruti Krishna , Srivathsan, Komandoor

Reviews in Cardiovascular Medicine | August 29, 2024 | Volume: 25 | Issue: 8 | Pages: No page available

10.31083/j.rcm2508299 | PMID 39228480 Get It

The landscape of cardiac pacemaker technology has undergone significant evolution over the last two decades, transitioning from simple single-chamber devices to sophisticated multi-chamber rate-responsive systems and cardioverter defibrillators. This progression has introduced a complex array of complications inherent to device implantation and operation, encompassing both mechanical and clinical challenges. These complications notably include lead dislodgment, device migration, venous thrombosis, and hemothorax, which not only affect patient outcomes but also impose substantial economic burdens. This review meticulously analyzes these complications, elucidating their mechanisms, clinical implications, and the economic consequences associated with their management. It also outlines current and emerging strategies aimed at mitigating these complications, emphasizing the need for continual updates in clinical practices and protocols. Through this discourse, the review seeks to equip clinicians with a comprehensive understanding of these complications, thereby enhancing the safety and efficacy of cardiac pacing interventions.
Beyond Transduction: Anti-Inflammatory Effects of Cell Penetrating Peptides
Lopuszynski, Jack , Wang, Jingyu , Zahid, Maliha , Zahid, Maliha , Wang, Jingyu

Molecules | August 29, 2024 | Volume: 29 | Issue: 17 | Pages: 4088

10.3390/molecules29174088 | PMID 39274936 Get It

One of the bottlenecks to bringing new therapies to the clinic has been a lack of vectors for delivering novel therapeutics in a targeted manner. Cell penetrating peptides (CPPs) have received a lot of attention and have been the subject of numerous developments since their identification nearly three decades ago. Known for their transduction abilities, they have generally been considered inert vectors. In this review, we present a schema for their classification, highlight what is known about their mechanism of transduction, and outline the existing literature as well as our own experience, vis a vis the intrinsic anti-inflammatory properties that certain CPPs exhibit. Given the inflammatory responses associated with viral vectors, CPPs represent a viable alternative to such vectors; furthermore, the anti-inflammatory properties of CPPs, mostly through inhibition of the NF-κB pathway, are encouraging. Much more work in relevant animal models, toxicity studies in large animal models, and ultimately human trials are needed before their potential is fully realized.
A Case of Nasoseptal Flap Reconstruction for Refractory Medial Canthal Fistula
Wang, Kenny Y. , Yu, Caroline , Tooley, Andrea A. , Yu, Caroline Y, Pinheiro-Neto, Carlos, Tooley, Andrea A , Pinheiro‐Neto, Carlos

Ophthalmic Plastic & Reconstructive Surgery | August 29, 2024 | Volume: 40 | Issue: 6 | Pages: e237-e240

10.1097/iop.0000000000002767 | PMID 39197178 Get It

Sino-orbital cutaneous fistulas (SOCFs) are a rare and challenging complication from conditions including granulomatosis with polyangiitis. SOCFs are difficult to manage due to poor vascular supply, compromised tissue, and systemic immunocompromise, which lead to a high rate of recurrence. Given the overall rarity of SOCFs, optimal surgical repair remains controversial, with options ranging from conservative management, onlay grafts, and vascularized flaps. This case report describes a novel one-step approach to SOCF closure using a composite chondral mucosal nasoseptal flap in a patient with a large left medial canthal SOCF that had recurred despite 2 prior attempts at closure including a vascularized paramedian forehead flap. Nasoseptal flaps may provide vascularized mucosal tissue to allow for greater success in closure over traditional, external flaps, and skin grafts.
Estimating glomerular filtration in young people
Derain‐Dubourg, Laurence, Björk, Jonas , Courbebaisse, Marie , Couzi, Lionel , Gaillard, F. , Grubb, Anders , Jacquemont, Lola, Legendre, Christophe , Littmann, Karin , Mariat, Christophe , Sundin, Per‐Ola , Berg, Ulla, Åsling‐Monemi, Kajsa, Åkesson, Anna , Pottel, Hans , Delanaye, Pierre , Björk, Jonas , Couzi, Lionel , Gaillard, Francois , Grubb, Anders , Littmann, Karin , Rostaing, Lionel , Sundin, Per-Ola , Larsson, Anders , Delanaye, Pierre , Dubourg, Laurence , Garrouste, Cyril , Hansson, Magnus , Kamar, Nassim , Rule, Andrew D. , Bökenkamp, Arend , Nyman, Ulf

Clinical Kidney Journal | August 29, 2024 | Volume: 17 | Issue: 9 | Pages: No page available

10.1093/ckj/sfae261 | PMID 39314869 Get It

ABSTRACT Background Creatinine-based equations are the most used to estimate glomerular filtration rate (eGFR). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), the re-expressed Lund-Malmö Revised (r-LMR) and the European Kidney Function Consortium (EKFC) equations are the most validated. The EKFC and r-LMR equations have been suggested to have better performances in young adults, but this is debated. Methods We collected data (GFR) measured by clearance of an exogenous marker (reference method), serum creatinine, age and sex from 2366 young adults (aged between 18 and 25 years) both from Europe and the USA. Results In the European cohorts (n = 1892), the bias (in mL/min/1.73 m²) was systematically better for the EKFC and r-LMR equations compared with the CKD-EPI equation [2.28, 95% confidence interval (1.59; 2.91), –2.50 (–3.85; –1.76), 17.41 (16.49; 18.47), respectively]. The percentage of estimated GFR within 30% of measured GFR (P30) was also better for EKFC and r-LMR equations compared with the CKD-EPI equation [84.4% (82.8; 86.0), 87.2% (85.7; 88.7) and 65.4% (63.3; 67.6), respectively]. In the US cohorts (n = 474), the bias for the EKFC and r-LMR equations was better than for the CKD-EPI equation in the non-Black population [0.97 (–1.69; 3.06), –2.62 (–5.14; –1.43) and 7.74 (5.97; 9.63), respectively], whereas the bias was similar in Black US individuals. P30 results were not different between the three equations in US cohorts. Analyses in sub-populations confirmed these results, except in individuals with high GFR levels (GFR ≥120 mL/min/1.73 m²) for whom the CKD-EPI equation might have a lower bias. Conclusions We demonstrated that both the EKFC and r-LMR creatinine-based equations have a better performance than the CKD-EPI equation in a young population. The only exception might be in patients with hyperfiltration.
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Lipton, Richard B. , Harriott, Andrea M. , Julia, Y., Smith, Jonathan H. , Stokes, Jonathan , Gandhi, Pranav , Jariwala‐Parikh, Krutika, Jensen, G., Trugman, Joel M. , Dodick, David W. , Lipton, R.B. , Ma, Julia Y, Jensen, Gabriel S, Dodick, David W

Neurology | August 29, 2024 | Volume: 103 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000209745 | PMID 39197113 Get It

A Systematic Review and Meta-Analysis of Physiologic Variables in Sheep Fetuses
Trad, Ayssa Teles Abrão , Felisbino, Sarah W, Schenone, Mauro , Teles Abrao Trad, Ayssa, Branda, Megan E. , Schenone, Mauro H

Comparative Medicine | August 29, 2024 | Volume: 74 | Issue: 5 | Pages: 313-319

10.30802/aalas-cm-24-033 | PMID 39197998 Get It

The fetal sheep model has been widely used in fetal therapy research. However, there is a significant degree of variability among published normal values. Our study aimed to evaluate the literature available on normal values for hemodynamics, blood gases, and acid-base status in the sheep fetus and to determine the best possible estimation of such physiologic values. We conducted a systematic review with a comprehensive search of several databases. We included 189 articles in the database and over 2,800 sheep fetuses. Analysis revealed a mean umbilical blood flow of 202 mL/kg/min (95% CI: 182 to 223); mean arterial pCO2 of 49.8 mm Hg (95% CI: 49.2 to 50.3); mean arterial pO2 of 22.3 mm Hg (95% CI: 21.9 to 22.7); mean arterial pH of 7.35 (95% CI: 7.3487 to 7.3562); and mean arterial oxygen saturation of 59.8 (95% CI; 58 to 61.7). Our findings were punctuated by a high heterogeneity, for which we conducted several subanalyses. The results showed high heterogeneity and small study effect in the literature available and provided our best assessment of relevant variables on normal hemodynamics, blood gases, and acid-base status in the fetus after using strategies to mitigate the risk of bias present in the literature.
Immune checkpoint blockade: timing is everything
Sinicrope, Frank A. , Turk, Mary Jo , Sinicrope, Frank A

Journal for ImmunoTherapy of Cancer | August 29, 2024 | Volume: 12 | Issue: 8 | Pages: e009722

10.1136/jitc-2024-009722 | PMID 39209456 Get It

Neoadjuvant immunotherapy effectively uses the in situ tumor as a reservoir of tumor antigens to promote systemic antitumor immunity. Studies indicate that intratumoral responses to immune checkpoint inhibitors (ICIs) are mediated by resident memory T cells cells that are sequestered in tumors and have specificity for a wide range of tumor antigens. ICI treatment produces de novo priming of CD8+ T cells in tumor and in tumor-draining lymph nodes, and can boost the antitumor immune response by blocking inhibitory checkpoint proteins that can turn off T cells within the tumor. Neoadjuvant ICI treatment can enhance both intratumoral and systemic antitumor immunity, including expansion of intratumoral T-cell clones which is strongly associated with pathological treatment response. Recent data have shown high rates of pathological response to neoadjuvant immunotherapy with prolongation of survival compared with adjuvant ICI therapy alone in patients with unresectable or advanced melanoma. These data suggest that removal of the reservoir of tumor-specific T cells in the tumor and draining nodes by surgical resection may remove a significant proportion of the patient’s antitumor immunity with the potential to compromise ICI outcomes.
Patient Initiated Follow-Up (PIFU): how can rheumatology departments start to reap the benefits? A consensus document
Sengupta, Raj , Cole, Zoe, Kyle, Stuart , MacDonald, Gordon, McKay, Kirsten, Irani, Anushka, Perry, Mark , Irani, Anushka , Irani, Anushka , Bukhari, Marwan , McKay, Kirsten

Rheumatology Advances in Practice | August 28, 2024 | Volume: 8 | Issue: 4 | Pages: No page available

10.1093/rap/rkae091 | PMID 39411286 Get It

Abstract Patient Initiated Follow-Up (PIFU) is gaining momentum in the NHS, aiming to optimize outpatient care amidst rising service demands. PIFU is valuable in rheumatology, where the increasing demand for ongoing management exacerbates the patient backlog. Importantly, PIFU has demonstrated comparable safety and outcomes to traditional care in numerous studies. PIFU empowers patients, drives personalized care, increases efficiency, and has the potential to reduce waiting lists by allowing services to focus on new and acute cases. Effective PIFU implementation includes careful selection of patients, educating patients and healthcare staff, well defined operational guidelines, and robust remote monitoring. Digital solutions can enhance PIFU through patient education, active remote monitoring and streamlined escalation. Electronic Patient Reported Outcome Measures (ePROMs) provide a suitable and safe metric to monitor patients remotely. Given the potential benefits, outpatient departments should consider investing in PIFU as a solution to current healthcare delivery challenges and as a means for future proofing clinical systems against increasing service demands.
Practice Readiness? Trends in Chief Resident Case Logs vs Subsequent Case Log Data in Clinical Practice
Corey, Zachary , Lehman, Erik , Lemack, Gary E. , Clifton, Marisa , Atiemo, Humphrey , Sorensen, Mathew D., Smith, Ryan P. , Buckley, Jill C. , Thompson, R. Houston, Badalato, Gina M., Wallen, Eric, Cain, Mark P., Wolf, J. Stuart , Klausner, Adam P. , Mehta, Akanksha , Lee, Richard S. , Breyer, Benjamin N. , Raman, Jay D.

Urology Practice | August 28, 2024 | Volume: 11 | Issue: 6 | Pages: 1007-1013

10.1097/upj.0000000000000676 | PMID 39196730 Get It

Reply by Authors
Hanchate, Kunal , Pathak, Ram A. , Thiel, David D. , Pak, Raymond , Maniaci, Michael, Lyon, Timothy D. , Lyon, Timothy D

Urology Practice | August 28, 2024 | Volume: 11 | Issue: 6 | Pages: 980-981

10.1097/upj.0000000000000671 | PMID 39196669 Get It